Naturalistic study of the early psychiatric use of citalopram in the United States

Depression and Anxiety

Volumn 16, Issue 3, 2002, Pages 121-127

  Rush, A John ^a   Bose, Anjana ^b   Heydorn, William E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Forest Laboratories   (United States)

Author keywords

Antidepressant; Citalopram; Depression; Selective serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION DISORDER; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; SOMNOLENCE; TREATMENT OUTCOME; UNITED STATES;

CHRONIC DISEASE; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 0036429911     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.10056     Document Type: Article

References (34)

1. Ballenger JC, Davidson JR, Lecrubier Y, et al. 1999. Consensus statement on the primary, care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 60(Suppl 7):54-61.
2. Baumann P, Larsen F. 1995. The pharmacokinetics of citalopram. Rev Contemp Pharmacother 6:287-295.
3. Benkert O, Grunder G, Wetzel H, et al. 1996. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 30:441-451.
4. Brown WA, Harrison W. 1995. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 56:30-34.
5. Donovan SJ, Quitkin FM, Stewart JW, et al. 1994. Duration of antidepressant trials: Clinical and research implications. J Clin Psychopharmacol 14:64-66.
6. Ekselius L, von Knorring L, Eberhard G. 1997. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharmacol 12:323-331.
7. Feighner JP, Overø K. 1999. Multicenter, placebo-controlled, fixed dose study of citalopram in moderate to severe depression. J Clin Psychiatry 60:824-830.
8. Greenblatt DJ, von Moltke EL, Harmatz JS, et al. 1998. Drug interactions with newer antidepressants: Role of human cytochromes P450. J Clin Psychiatry 59(Suppl 15):19-27.
9. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. 1999. Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions. J Clin Psychopharmacol 19(Suppl 1):23S-35S.
10. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology Revised. US Department of Health, Education, and Welfare ADM 76-338. Washington, DC: Superintendent of Documents, US Government Printing Office.
11. Hirschfeld RMA. Citalopram Dosing of Depressed Patients by US Psychiatrists. Poster presentation, American Psychiatric Association, Washington, DC, May 20, 1999.
12. Hochstrasser B, Isaksen PM, Koponen H, et al. 2001. Prophylactic effect of citalopram in unipolar, recurrent depression: Placebocontrolled study of maintenance therapy. Br J Psychiatry 178:304-310.
13. Joffe RT, Levitt AJ, Sokolov ST, et al. 1996. Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 57:114-115.
14. Keller MB. 2000. Citalopram therapy for depression: A review of 10 years of European experience and data from U.S. clinical trials. J Clin Psychiatry 61:896-908.
15. Kyle CJ, Petersen HE, Overo KF. 1998. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress Anxiety 8:147-153.
16. Mendels J, Kiev A, Fabre LF. 1999. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety 9:54-60.
17. Montgomery SA, Djarv L. 1996. The antidepressant efficacy of citalopram. Int Clin Psychopharmacol 11(Suppl):129-133.
18. Montgomery SA, Rasmussen JG, Tanghøj P. 1993. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 8:181-188.
19. Nierenberg AA, McLean NE, Alpert JE, et al. 1995. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152:1500-1503.
20. Noble S, Benfield P. 1997. Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 8:410-431.
21. Nurnberg HG, Thompson PM, Hensley PL. 1999. Antidepressant medication change in a clinical treatment setting: A comparison of the effectiveness of selective serotonin reuptake inhibitors. J Clin Psychiatry 60:574-579.
22. Patris M, Bouchard JM, Bougerol T, et al. 1996. Citalopram versus fluoxetine: A double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacol 11:129-136.
23. Quitkin FM, Rabkin JG, Ross D, et al. 1984. Duration of antidepressant drug treatment. What is an adequate trial? Arch Gen Psychiatry 41:238-245.
24. Robert P, Montgomery SA. 1995. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebo-controlled 6 month study. Int Clin Psychopharmacol 10(Suppl 1):29-35.
25. Rosenberg C, Damsbo N, Fuglum E, et al. 1994. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study: Int Clin Psychopharmacol 9(Suppl):141-148.
26. Rush AJ, Giles DE, Schlesser MA, et al. 1986. The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Res 18:65-87.
27. Rush AJ, Gullion CM, Basco MR, et al. 1996. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 26:477-486.
28. Schweizer E, Rickels K, Amsterdam JD, et al. 1990. What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry 51:8-11.
29. Stahl SM. 2000. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 48:894-901.
30. Thase ME, Feighner JP, Lydiard RB. 2001. Citalopram treatment of fluoxetine nonresponders. J Clin Psychiatry 62:683-687.
31. Thase ME, Ferguson J, Wilcox C. Citalopram Treatment of Paroxetine Intolerant Patients. Poster presentation, New Clinical Drug Evaluation Unit (NCDEU), Boca Raton, FL, June 1-4, 1999.
32. Thase ME, Rush AJ. 1997. When at first you don't succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58(Suppl 13):23-29.
33. Trivedi MH, Rush AJ, Pan J-Y, Carmody TC. 2001. Which depressed patients respond to nefazodone and when? J Clin Psychiatry. 62:158-163.
34. Willetts J, Lippa A, Beer B. 1999. Clinical development of citalopram. J Clin Psychopharmacol 19(Suppl 1):36S-46S.